Nektar Therapeutics (NKTR) Net Equity Issued and Repurchased (2010 - 2026)
Nektar Therapeutics' (NKTR) quarterly Net Equity Issued and Repurchased came in at $93.1 million in Q1 2026, up 26.5% quarter-over-quarter from $73.6 million in Q4 2025.
Nektar Therapeutics (NKTR) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
Nektar Therapeutics' Net Equity Issued and Repurchased history runs 5 years deep, the most recent figure standing at $93.1 million for Q1 2026.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $93.1 million in Q1 2026; TTM through Mar 2026 was $201.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $108.1 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased advanced to $93.1 million in Q1 2026 per NKTR's latest filing, from $73.6 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $93.1 million in Q1 2026 and bottomed at $34.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Nektar Therapeutics | 2.04 Bn | 1.48 Bn | 3.16 Mn | 93.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 93.12 Mn |
| Mar 31, 2026 | 93.12 Mn |
| Dec 31, 2025 | 73.61 Mn |
| Dec 31, 2025 | 73.61 Mn |
| Sep 30, 2025 | 34.30 Mn |
| Sep 30, 2025 | 34.30 Mn |
| Mar 31, 2012 | 479,000.00 |
| Mar 31, 2012 | 479,000.00 |
| Dec 31, 2011 | -4.29 Mn |
| Dec 31, 2011 | -4.29 Mn |
| Sep 30, 2011 | 523,000.00 |
| Sep 30, 2011 | 523,000.00 |
| Jun 30, 2011 | 1.59 Mn |
| Jun 30, 2011 | 1.59 Mn |
| Mar 31, 2011 | 221.96 Mn |
| Mar 31, 2011 | 221.96 Mn |
| Dec 31, 2010 | 1.75 Mn |
| Dec 31, 2010 | 1.75 Mn |
| Sep 30, 2010 | 994,000.00 |
| Sep 30, 2010 | 994,000.00 |